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Introduction
Diagnostic testing has traditionally been conducted in a laboratory setting, and requires highly-
skilled operators working in strictly-controlled laboratory environments. The recent availability 
of point-of-care (POC) technologies allows for a shift from a centralised to a decentralised model 
of testing. Such decentralisation of testing can offer a significant increase in access to much needed 
diagnostics for populations in peri-urban, rural and other hard to reach areas, which will be 
needed to achieve the UNAIDS 90-90-90 target.1 Furthermore, the scale up of quality POC testing 
can help strengthen health systems, especially in rural areas.2
The wide deployment of POC tests at hundreds or even thousands of sites raises a big challenge 
for Ministries of Health to track instruments and monitor the quality of the test and the testing. In 
order to address these concerns, numerous connectivity (connected diagnostic) initiatives and 
interventions have been undertaken in an attempt to ensure that the implementing institution is 
able to keep track of, at minimum, key performance and operational metrics for devices in the 
field. These initiatives have had mixed success in implementation due to a variety of reasons. 
Companies are now either embedding connectivity in their new diagnostic instruments or 
providing some form of channel for electronic result exchange.
Zimbabwe, for example, has placed 346 Alere Pima™ POC CD4 devices in hard to reach areas 
throughout the country. At present, 114 of these instruments are connected via Alere 3G modems 
to the Clinton Health Access Initiative’s in-country POCLabs platform in conjunction with the 
National Microbiology Reference Laboratory. The Ministry of Health has been receiving scant 
data from the devices, as is shown in the snapshot provided in Table 1. This is likely due to a 
combination of reasons including: lack of awareness regarding sending of data, insufficient 
2G/3G signal, SIM cards with insufficient/expired airtime, and other SIM issues.
External quality assessment challenges for 
point-of-care testing
External quality assessment (EQA) is a critical component of a laboratory quality assurance and 
management system.3 EQA for POC testing has the potential to provide a snapshot of quality, 
both in terms of the diagnostic instrument performance as well as the competency of the operator. 
Point-of-care (POC) tests have been useful in increasing access to testing and treatment 
monitoring for HIV. Decentralising testing from laboratories to hundreds of sites around a 
country presents tremendous challenges in training and quality assurance. In order to address 
these concerns, companies are now either embedding connectivity in their new POC diagnostic 
instruments or providing some form of channel for electronic result exchange. These will allow 
automated key performance and operational metrics from devices in the field to a central 
database. Setting up connectivity between these POC devices and a central database at the 
Ministries of Health will allow automated data transmission, creating an opportunity for real-
time information on diagnostic instrument performance as well as the competency of the 
operator through external quality assessment. A pilot programme in Zimbabwe shows that 
connectivity has significantly improve the turn-around time of external quality assessment 
result submissions and allow corrective actions to be provided in a timely manner. Furthermore, 
by linking the data to existing supply chain management software, stock-outs can be 
minimised. As countries are looking forward to achieving the 90-90-90 targets for HIV, such 
innovative technologies can automate disease surveillance, improve the quality of testing and 
strengthen the efficiency of health systems.
Data connectivity: A critical tool for 
external quality assessment
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The implementation of POC testing in rural and peri-urban 
settings, however, presents tremendous challenges in the 
organisation of an EQA programme. These challenges include:
•	 The scale of providing EQA samples to hundreds of sites 
within a country, requiring the preparation or procurement 
of a large number of proficiency testing panels and the 
means to distribute them.
•	 POC tests are typically operated by non-laboratory staff 
who are not familiar with a laboratory ‘culture’ of quality 
or EQA.
•	 Poor response rates and delay in reporting weaken the 
value of EQA programmes.
How can connectivity improve the quality of 
testing?
Connectivity for POC tests and other medical devices can be 
defined as an initiative that can improve patient flow, increase 
the quality of testing, and improve patient outcomes. 
Connectivity should be viewed as a complementary approach 
to EQA. It can provide continuous quality monitoring, as all 
of the data generated by the instrument can be analysed as an 
average of a series of aggregated, non-unique events, whereas 
EQA is a series of controlled events, with known inputs and 
known outputs. Connectivity can be used not only to monitor 
patient data such as diagnostic results and response to 
treatment, but it can also be used to capture operational data 
from the device and provide key performance and quality 
indicators.
Most POC instruments now include methods to exchange 
data electronically. This can be via a port (e.g., USB, Ethernet, 
serial), or via embedded GSM/3G capabilities within the 
POC device. The diagnostics industry is beginning to take 
full advantage of these capabilities with a number of 
ecosystems being constructed around the consumption of 
this data. Various stakeholders have distinct, and well-
defined needs for the different data sets and subsets. Broadly, 
the data can be categorised into clinical data, which includes 
patient-identifiable information, and operational data. 
Operational data is defined as a subset of the clinical data 
which is de-identified. These systems allow Ministries of 
Health to receive information and derive intelligence, in real-
time, from any testing facility throughout a country into one 
central database. This allows Ministries of Health to have 
daily monitoring of the performance of the devices, the test 
results and the competency of the operators from each site. 
Furthermore, connectivity can help improve forecasting and 
prevent stock-outs based on the utilisation rate at each 
facility, as shown in Figure 1.
Operational data can be used by instrument manufacturers, 
Ministries of Health, funders, trainers, and supply chain 
managers. Diagnostic data can be used for patient 
management by nurses, clinicians and epidemiologists and 
stored in a laboratory information system and/or a central 
data warehouse.4 These informatics systems are continually 
expanding and innovating features as the ecosystems become 
better defined. One example is the automated detection and 
transmission of EQA samples from diagnostic devices which 
is made available, in near-real time, to the EQA providers for 
analysis.
Existing point-of-care external quality 
assessment structure for the Pima CD4 in 
Zimbabwe
Historically, the Pima CD4 EQA programme in Zimbabwe 
requires a significant amount of hands-on time for both 
sample shipping, testing and reporting. The process, briefly, 
is as follows.
EQA samples are shipped to a single, central, location for 
separation and distribution. This facility unpacks the samples 
and re-packages them for distribution by courier for delivery 
to the facility (Figure 2). After the samples have been received 
by the testing facility, they are required to be completed 
TABLE 1: Snapshot of reporting frequency from connected devices in Zimbabwe, 
2016.
Last data received Number of sites reporting
0–10 days 4
11–30 days 21
31–60 days 9
61–90 days 8
90 days or more 72
Total number of instruments 114
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FIGURE 1: Using connectivity to monitor utilisation and predict stock-outs. 
Source: Alex Freller, OneWorld Accuracy
FIGURE 2: Sample EQA set sent to sites in Zimbabwe.
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before the scheduled deadline, and the results are reported, 
via different mechanisms, back to the central facility.
Once the EQA deadline closes, the central facility captures all of 
the received results, first on paper for central collection, and 
then via a web-form on the EQA provider’s informatics 
platform, for all participating sites. Once the EQA results have 
been captured and submitted, the EQA provider is able to 
analyse the results and report these, with any corrective action 
suggestions, back to the central facility. At this point, the central 
facility is, again, responsible for separating the individual 
performance reports for the facilities and re-distributing these, 
along with any corrective actions, back to the participants. This 
whole process usually takes at least 12 weeks.
For connected devices, it is clear that a much simpler and 
more efficient workflow can be leveraged to optimise the 
EQA process. POC tests connected to an informatics system 
capable of distinguishing EQA from routine samples via the 
sample ID can dramatically help improve turnaround time 
for EQA results, thereby allowing for action to be taken if 
necessary. Furthermore, there will be significantly fewer 
transcription errors and data analysis will be simplified.
Proof of concept for an automated 
external quality assessment 
programme in Zimbabwe
An automated EQA proof-of-concept pilot for CD4 counts 
was conducted in November 2015 in Manicaland Province 
in Zimbabwe. Several issues had to be resolved among 
different partners before the proof-of-concept testing could 
be initiated. A standardised barcoding format had to be 
agreed upon for use as the sample ID for testing on the Pima 
CD4 instrument. The barcode standardisation was necessary 
so that the informatics systems would be able to differentiate 
EQA samples from patient results to ensure that no patient 
data is transmitted beyond the clinical boundaries defined in 
these structures (Figure 3).
Alere, the developer of the Pima POC CD4 device developed 
an ‘EQA only’ data-store and interface for its centralised 
data warehouse, Data Point. This allows for authorised, 
external systems to query Data Point for samples that have 
been identified as EQA samples from the barcode. For this 
pilot, the EQA provider, Oneworld Accuracy, developed 
an application program interface for their informatics 
system, OASYS (Oneworld Accuracy System), which would 
automatically query Data Point every hour for any new 
data that has been identified as an EQA sample. All 
new data identified as EQA are then immediately received 
by OASYS for storage and processing (both of these 
application program interfaces have now been included in 
the production version of both Data Point and OASYS).
The proof-of-concept study only involved one site, the 
Marange rural health centre. Three sets of EQA samples 
were delivered to Marange and run by the operator over a 
three-week period. Oneworld Accuracy received the results 
from the EQA samples within 60 minutes of these tests 
being performed on the Pima device, demonstrating that 
the automated system performed as expected. The next 
phase was to increase the number of sites to approximately 
50 and EQA samples were distributed as part of the 
routinely-scheduled EQA assessment planned for the end 
of March 2016.
Due to the perceived impact of this intervention, a similar 
process is currently being established to automate the 
reporting of EQA samples (identified by a barcode) from the 
Cepheid GeneXpert® platform to the relevant EQA provider 
informatics systems. The proof-of-concept testing for this 
took place in April 2016 at four sites in Manicaland.
Post-proof of concept
The proof-of-concept pilot highlighted the potential for 
improvement in turn-around time from testing to reporting 
of EQA results, as well as reducing the overall administrative 
Proposed a standardized EQA sample barcoding format to be used as the sample ID for tesng on the PIMA CD4 instrument.
Alere developed an “EQA-only” data interface for authorized, external systems to query for samples which have been
idenfied as EQA from the barcode.
OneWorld developed an API exchange on their Oasys system which could automacally query Data Point (every hour)
for any new data which has been idenfied as an EQA sample
EQA samples automacally received by the EQA provider & reported in significantly reduced me-frame.
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FIGURE 3: Steps involved in the automated EQA reporting proof-of-concept, Manicaland Province, Zimbabwe, November 2015. 
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burden of these events. It is recommended that some standard 
barcoding identification be implemented for all EQA samples 
for both laboratory and POC instruments. The implementation 
of a standardised barcode structure for the identification 
of EQA samples would allow any informatics system 
(operational or clinical), connected to any laboratory or POC 
instrument, to identify a sample as an EQA sample and 
transmit these results, in near-real time, to the relevant EQA 
provider for analysis and reporting.
In the ideal case, the following workflow could become 
standard for EQA testing and reporting:
•	 The EQA provider sends out the sample to the test site.
•	 The test site receives the sample and tests the sample.
•	 The results are automatically uploaded to a server upon 
completion.
•	 The server identifies the result as an EQA result and 
forwards the result to the correct EQA provider.
•	 The EQA provider scores the result and generates the 
user report.
This proposed workflow reduces the need for the paper 
transcription of results to be collected centrally, as well as 
the need for the collected results to be re-transcribed in an 
electronic format on the EQA provider’s informatics platform, 
thus reducing errors in both interpretation and transcription.
Way forward
The automation of the collection and analysis of EQA results 
from laboratories, especially for POC instruments, can help 
countries:
•	 Significantly improve the turn-around time of EQA result 
submissions and the impact of any prescribed corrective 
actions in a timely manner.
•	 Reduce the transcription error rate and improve the quality 
of the resulting process.
•	 Eliminate the time-consuming processes involved with 
EQA result collection, capture and re-distribution.
•	 Reduce the cost and improve uptake of EQA programmes 
for both laboratories and POC facilities.
Additional expected outputs from this pilot are:
•	 Feasibility and acceptability from EQA providers to adhere 
to a standardised barcode format.
•	 Willingness for Ministries of Health to have this data 
(non-patient data) automatically shared between connected 
systems (and ecosystems) from the instrument to the EQA 
provider.
•	 Definition of the role the instrument manufacturer can 
play in helping countries successfully implement and 
monitor EQA programmes via manufacturer platforms.
Conclusion
Connectivity has shown that it is possible for Ministries of 
Health to have up-to-the-hour information on testing and test 
results across the country. These results can also be accompanied 
by EQA results from laboratories, as well as each POC testing 
site across the country, so that corrective action and refresher 
training can be provided in a timely manner. These systems 
can also be twinned to supply chain management software to 
monitor supplies at each site, providing an automated system 
for alerts to avoid stock-outs. As countries are looking forward 
to achieving the 90-90-90 targets for HIV, such innovative 
technologies can automate surveillance, improve quality of 
testing and strengthen health systems.
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